Evaluation of the Correlation between Serum Concentrations of Asymmetric Dimethylarginine and Corrected TIMI Frame Count in Patients with Slow Coronary Flow

Evaluation of the Correlation between Serum Concentrations of Asymmetric Dimethylarginine and Corrected TIMI Frame Count in Patients with Slow Coronary Flow

Coronary slow flow (CSF) is an important angiographic entity that is characterized by delayed opacification of coronary arteries in the absence of epicardial occlusive disease. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase. Elevated levels of ADMA cause the i...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mahshid Naserifar, Mahshid Ataei, Nadia Behzadian, Amir Hooshang Mohammadpour, Mostafa Dastani, Amirhossein Sahebkar, Hesamoddin Hosseinjani
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	International Journal of Vascular Medicine
Online Access:	http://dx.doi.org/10.1155/2020/4592190
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Corrigendum to “Evaluation of the Correlation between Serum Concentrations of Asymmetric Dimethylarginine and Corrected TIMI Frame Count in Patients with Slow Coronary Flow”
by: Mahshid Naserifar, et al.
Published: (2020-01-01)

Harnessing Therapeutic Potentials of Statins Using Nanofibrous Carriers
by: Mahshid Ataei, et al.
Published: (2021-01-01)

Helicobacter pylori Eradication Lowers Serum Asymmetric Dimethylarginine Levels
by: Selim Aydemir, et al.
Published: (2010-01-01)

Asymmetric dimethylarginine and NO metabolites in patients with acute and chronic coronary heart disease
by: A. S. Galyavich, et al.
Published: (2009-02-01)

Perinatal risk factors affecting the maternal and fetal asymmetric dimethylarginine levels
by: Mustafa Kul, et al.
Published: (2009-04-01)

Among Ectasia Patients with Coexisting Coronary Artery Disease, TIMI Frame Count Correlates with Ectasia Size and Markis Type IV Is the Commonest
by: Hasahya Tony, et al.
Published: (2015-01-01)

Endogenous Symmetric Dimethylarginine (SDMA) and Asymmetrical Dimethylarginine (ADMA) Levels in Healthy Cows and Cows with Subclinical and Clinical Mastitis—A Comparative Study
by: Valerio Bronzo, et al.
Published: (2025-02-01)

Renal Function but Not Asymmetric Dimethylarginine Is Independently Associated with Retinopathy in Type 2 Diabetes
by: Katarzyna Krzyzanowska, et al.
Published: (2011-01-01)

Asymmetric Dimethylarginine Blocks Nitric Oxide-Mediated Alcohol-Stimulated Cilia Beating
by: T. A. Wyatt, et al.
Published: (2013-01-01)

The issue of plasma asymmetric dimethylarginine reference range - A systematic review and meta-analysis.
by: Balázs Németh, et al.
Published: (2017-01-01)

Oxidative Stress in Psoriasis Vulgaris Patients: Analysis of Asymmetric Dimethylarginine, Malondialdehyde, and Glutathione Levels
by: Neşe Göçer Gürok, et al.
Published: (2025-05-01)

Flow-Mediated Dilatation and Asymmetric Dimethylarginine Do Not Predict Mortality in Peritoneal Dialysis Patients
by: Sami Uzun, et al.
Published: (2017-09-01)

TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
by: John W Petersen, et al.
Published: (2014-01-01)

Effect of a Supervised Peridialytic Exercise Program on Serum Asymmetric Dimethylarginine in Maintenance Hemodialysis Patients
by: Yaser A. Ammar, et al.
Published: (2020-01-01)

L-Arginine and Asymmetric Dimethylarginine Are Early Predictors for Survival in Septic Patients with Acute Liver Failure
by: Thorsten Brenner, et al.
Published: (2012-01-01)

Intercellular Adhesion Molecule and Endogenous NOS Inhibitor: Asymmetric Dimethylarginine in Pregnant Women with Gestational Diabetes Mellitus
by: Elżbieta Poniedziałek-Czajkowska, et al.
Published: (2016-01-01)

Efficacy of Urine Asymmetric Dimethylarginine Concentration to Predict Azotemia in Hyperthyroid Cats After Radio‐Iodine Treatment
by: Ellen Vanden Broecke, et al.
Published: (2025-05-01)

A multicenter study of asymmetric and symmetric dimethylarginine as predictors of mortality risk in hospitalized COVID-19 patients
by: Juliane Hannemann, et al.
Published: (2024-07-01)

Serum Levels of Asymmetric Dimethylarginine and Apelin as Potential Markers of Vascular Endothelial Dysfunction in Early Rheumatoid Arthritis
by: Manuela Di Franco, et al.
Published: (2012-01-01)

Increased asymmetric dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcome.
by: Tsin W Yeo, et al.
Published: (2010-04-01)

Comparison of Asymmetric Dimethylarginine Levels Between Stages Three, Four, and Five Non-dialysis of Chronic Kidney Disease
by: Tri P Asmarawati, et al.
Published: (2016-09-01)

Saturation kinetics and specificity of transporters for L-arginine and asymmetric dimethylarginine (ADMA) at the blood-brain and blood-CSF barriers.
by: Mehmet Fidanboylu, et al.
Published: (2025-01-01)

The effect of α-lipoic acid treatment on plasma asymmetric dimethylarginine, a biomarker of endothelial dysfunction in diabetic neuropathy
by: Ferenc Sztanek, et al.
Published: (2020-12-01)

Comparison of Asymmetric Dimethylarginine Levels Between Stages Three, Four, and Five Non-dialysis of Chronic Kidney Disease
by: Tri P Asmarawati, et al.
Published: (2016-09-01)

Changes in the system of asymmetric dimethylarginine - endothelial NO-synthase in patients with acute myocardial infarction and type 2 diabetes mellitus
by: D. V. Minukhina, et al.
Published: (2018-12-01)

Saturation kinetics and specificity of transporters for L-arginine and asymmetric dimethylarginine (ADMA) at the blood-brain and blood-CSF barriers
by: Mehmet Fidanboylu, et al.
Published: (2025-01-01)

Association of dietary phytochemical index with metabolic markers, serum asymmetric dimethylarginine and atherogenic indices in patients with polycystic ovary syndrome
by: Farshad Amirkhizi, et al.
Published: (2025-05-01)

Asymmetric Dimethylarginine as a Potential Mediator in the Association between Periodontitis and Cardiovascular Disease: A Systematic Review of Current Evidence
by: Biagio Rapone, et al.
Published: (2024-09-01)

Author Correction: A multicenter study of asymmetric and symmetric dimethylarginine as predictors of mortality risk in hospitalized COVID-19 patients
by: Juliane Hannemann, et al.
Published: (2025-04-01)

Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies.
by: Sabrina Schlesinger, et al.
Published: (2016-01-01)

Asymmetric rotations slow down diffusion under confinement
by: Zhiqiang Liu, et al.
Published: (2025-02-01)

MANAGEMENT OF SOIL RESOURCES IN GIARMATA, TIMIŞ COUNTY, ROMANIA
by: Anișoara DUMA COPCEA, et al.
Published: (2021-01-01)

AGRICULTURE AND SUSTAINABLE SOIL USE IN TIMIŞ COUNTY, ROMANIA
by: Saida FEIER DAVID, et al.
Published: (2020-01-01)

Association of Serum Symmetric Dimethylarginine Concentrations and Inflammation in Cats
by: Giulia Cattaneo, et al.
Published: (2025-03-01)

Increased level of serum asymmetric dimethylarginine in individuals with more severe cognitive impairment, as evaluated using Montreal Cognitive Assessment instead of Mini-Mental State Examination
by: Lei Liu, et al.
Published: (2025-04-01)

Effect of fenbendazole treatment in an ovine Dictiocaulosis episode in Timis County
by: Stancu, C. Adrian
Published: (2017-12-01)

Amlodipine improves symmetric dimethylarginine in dogs with chronic kidney disease
by: Shohei Morita, et al.
Published: (2025-04-01)

Tracking Control for Asymmetric Underactuated Sea Vehicles in Slow Horizontal Movement
by: Przemyslaw Herman
Published: (2025-07-01)

The effect of treatment with Amprolium and Sulfadiarom in an episode of ovine coccidiosis in Timis County
by: Stancu C. Adrian
Published: (2017-12-01)

DECLARE-TIMI 58 trial in the context of EMPA-REG OUTCOME and CANVAS
by: Marina V. Shestakova
Published: (2019-12-01)